Sera Prognostics, Inc. Class A Common Stock
$2.09
$0.02 (+0.72%)
$2.07Day Range$2.16
Key Statistics
Market Cap
$82.25M
Shares Outstanding
39.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 15, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$2.07
Day High
$2.16
Day Low
$2.07
Volume
92.1K
VWAP
$2.10
Prev Close
$2.07
Transactions
--
Acc. Volume
--
About Sera Prognostics, Inc. Class A Common Stock
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
SERVICES-MEDICAL LABORATORIESSIC 807172 employees2749 E. PARLEYS WAY, SALT LAKE CITY, UT, 84109(801) 990-0520IPO Jul 15, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001534969
- Composite FIGI
- BBG001J19ZJ7
- Share Class FIGI
- BBG001V0FR24
- Ticker Root
- SERA
- SIC Code
- 8071
About Sera Prognostics, Inc. Class A Common Stock (SERA) Stock
Sera Prognostics, Inc. Class A Common Stock (SERA) closed the 2026-09-18 session at $2.08, up 0.72% versus the previous close (+0.02). The stock opened at $2.07 and traded between $2.07 and $2.16 during that session. Session trading volume was 92K shares. The volume-weighted average price (VWAP) is $2.10.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Sera Prognostics, Inc. Class A Common Stock has a market capitalization of $82.3 million. The company operates in the SERVICES-MEDICAL LABORATORIES industry classification. SERA is listed on the XNAS exchange. The company employs approximately 72 people. Sera Prognostics, Inc. Class A Common Stock is headquartered in SALT LAKE CITY, UT. The recorded listing date is 2021-07-15.
On this page you can find market SERA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MEDICAL LABORATORIES sector.